MRI criteria for MS in patients with clinically isolated syndromes.

MRI criteria for MS in patients with clinically isolated syndromes.

In recent years, criteria for the diagnosis of multiple sclerosis (MS) have changed, mainly due to the incorporation of new MRI criteria. While the new criteria are a logical step forward, they are complex and-not surprisingly-a good working knowledge of them is not always evident among neurologists...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Montalban, X, Tintoré, M, Swanton, J, Barkhof, F, Fazekas, F, Filippi, M, Frederiksen, J, Kappos, L, Palace, J, Polman, C, Rovaris, M, de Stefano, N, Thompson, A, Yousry, T, Rovira, A, Miller, D
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2010

Ижил төстэй зүйлс

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.
-н: Seewann, A, зэрэг
Хэвлэсэн: (2008)

Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study.
-н: Rocca, M, зэрэг
Хэвлэсэн: (2009)

The current role of MRI in differentiating multiple sclerosis from its imaging mimics
-н: Geraldes, R, зэрэг
Хэвлэсэн: (2018)

MRI assessment of iron deposition in multiple sclerosis.
-н: Ropele, S, зэрэг
Хэвлэсэн: (2011)

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.
-н: Wegner, C, зэрэг
Хэвлэсэн: (2008)

Functional connectivity changes of the motor network in patients with multiple sclerosis: a multicentre fMRI study
-н: Rocca, M, зэрэг
Хэвлэсэн: (2009)

Functional connectivity changes of the motor network in patients with multiple sclerosis: a multi-centre fMRI study
-н: Filippi, M, зэрэг
Хэвлэсэн: (2009)

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
-н: Matthews, L, зэрэг
Хэвлэсэн: (2014)

Intercenter differences in diffusion tensor MRI acquisition.
-н: Pagani, E, зэрэг
Хэвлэсэн: (2010)

Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
-н: Korteweg, T, зэрэг
Хэвлэсэн: (2009)

Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
-н: Wallner-Blazek, M, зэрэг
Хэвлэсэн: (2014)

Erratum: Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis (Journal of Neurology (2013) 260 (2016-2022) DOI: 10.1007/s00415-013-6918-y)
-н: Wallner-Blazek, M, зэрэг
Хэвлэсэн: (2014)

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition.
-н: Manson, S, зэрэг
Хэвлэсэн: (2008)

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
-н: Wallner-Blazek, M, зэрэг
Хэвлэсэн: (2013)

Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis
-н: Wallner-Blazek, M, зэрэг
Хэвлэсэн: (2013)

Reproducibility of fMRI in the clinical setting: implications for trial designs.
-н: Bosnell, R, зэрэг
Хэвлэсэн: (2008)

Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis.
-н: Mancini, L, зэрэг
Хэвлэсэн: (2009)

MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies
-н: Nicola De Stefano, зэрэг
Хэвлэсэн: (2022-01-01)

Optimising diffusion measurements for large-scale, multicentre multiple sclerosis trials: a pan-European study
-н: Perego, E, зэрэг
Хэвлэсэн: (2008)

Optimizing diffusion measurements for large-scale, multicenter multiple sclerosis trials: a pan-European study
-н: Rovaris, M, зэрэг
Хэвлэсэн: (2008)

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.
-н: Filippi, M, зэрэг
Хэвлэсэн: (2004)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
-н: Vrenken, H, зэрэг
Хэвлэсэн: (2013)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
-н: Vrenken, H, зэрэг
Хэвлэсэн: (2013)

Association between pathological and MRI findings in multiple sclerosis.
-н: Filippi, M, зэрэг
Хэвлэсэн: (2012)

Association between pathological and MRI findings in multiple sclerosis
-н: Filippi, M, зэрэг
Хэвлэсэн: (2012)

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
-н: Nielsen Jessica M, зэрэг
Хэвлэсэн: (2009-05-01)

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
-н: Houshang Amiri, зэрэг
Хэвлэсэн: (2018-01-01)

Brain MRI atrophy quantification in MS: From methods to clinical application.
-н: Rocca, M, зэрэг
Хэвлэсэн: (2016)

BEFORE AND AFTER THE ACUTE MS LESION: A LONGITUDINAL DTI STUDY
-н: Giorgio, A, зэрэг
Хэвлэсэн: (2009)

Improved MRI-derived assessment of grey and white matter volumes by using SIENAX
-н: Battaglini, M, зэрэг
Хэвлэсэн: (2013)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
-н: Jurynczyk, M, зэрэг
Хэвлэсэн: (2016)

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.
-н: Georgina Arrambide, зэрэг
Хэвлэсэн: (2013-01-01)

MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex.
-н: Parry, A, зэрэг
Хэвлэсэн: (2003)

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
-н: Jasperse, B, зэрэг
Хэвлэсэн: (2007)

Diagnostic Criteria for Pediatric MS
-н: J Gordon Millichap
Хэвлэсэн: (2013-06-01)

Partnership and consent in MS treatment choice.
-н: Palace, J
Хэвлэсэн: (2013)

Partnership and consent in MS treatment choice
-н: Palace, J
Хэвлэсэн: (2013)

The UK MS database
-н: Palace, J, зэрэг
Хэвлэсэн: (2002)

Clinical and laboratory characteristics of secondary progressive MS.
-н: Palace, J
Хэвлэсэн: (2003)

To differentiate the indication to treat the clinically isolated syndrome on the bases of different clinical onsets. The subgroup analyses from a Cochrane meta-analysis
-н: Clerico, M, зэрэг
Хэвлэсэн: (2009)